Literature DB >> 19006455

The ROCK inhibitor Y-27632 enhances the survival rate of human embryonic stem cells following cryopreservation.

Xiangyun Li1, Guoliang Meng, Roman Krawetz, Shiying Liu, Derrick E Rancourt.   

Abstract

After slow freezing, the survival rate of human embryonic stem (hES) cells is poor and inconsistent. The aim of this study was to increase the freeze-thaw survival rate of hES cells by utilizing the ROCK inhibitor Y-27632. hES cell colonies were first treated with Y-27632, followed by collagenase IV and TrypLE Select dissociation whereupon small clumps were slow frozen using 90% Knockout serum replacement and 10% dimethyl sulfoxide. After thawing at 37 C, the clumps were cultured in medium supplemented with 10 microM Y-27632 for 1 day. Our results show that the use of Y-27632 significantly increases the survival of hES cells after thawing compared with that of the control group. Y-27632-treated freeze-thawed hES cells retain morphology, stable karyotype, expression of cell surface markers, and the potential to differentiate into derivatives of all three germ layers after long-term culture. We have concluded that conventional slow freezing with Y-27632 treatment is efficient and convenient for the cryopreservation of hES cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19006455     DOI: 10.1089/scd.2007.0247

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  39 in total

Review 1.  Cryopreservation of human pluripotent stem cells in defined medium.

Authors:  Weiwei Liu; Guokai Chen
Journal:  Curr Protoc Stem Cell Biol       Date:  2014-11-03

Review 2.  The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis.

Authors:  Rachel S Knipe; Andrew M Tager; James K Liao
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

3.  Effects of cryopreservation on the transcriptome of human embryonic stem cells after thawing and culturing.

Authors:  Vilas Wagh; Kesavan Meganathan; Smita Jagtap; John Antonydas Gaspar; Johannes Winkler; Dimitry Spitkovsky; Jürgen Hescheler; Agapios Sachinidis
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

4.  Guided migration of neural stem cells derived from human embryonic stem cells by an electric field.

Authors:  Jun-Feng Feng; Jing Liu; Xiu-Zhen Zhang; Lei Zhang; Ji-Yao Jiang; Jan Nolta; Min Zhao
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

5.  Effect of small molecule supplements during in vitro culture of mouse zygotes and parthenogenetic embryos on hypoblast formation and stem cell derivation.

Authors:  K Versieren; M Van der Jeught; T O'Leary; G Duggal; J Gerris; S Chuva de Sousa Lopes; B Heindryckx; P De Sutter
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

6.  Rho-associated protein kinase inhibition enhances airway epithelial Basal-cell proliferation and lentivirus transduction.

Authors:  Amjad Horani; Aditya Nath; Mollie G Wasserman; Tao Huang; Steven L Brody
Journal:  Am J Respir Cell Mol Biol       Date:  2013-09       Impact factor: 6.914

7.  Cryopreservation of Human Stem Cells for Clinical Application: A Review.

Authors:  Charles J Hunt
Journal:  Transfus Med Hemother       Date:  2011-03-16       Impact factor: 3.747

8.  Presence of a ROCK inhibitor in extracellular matrix supports more undifferentiated growth of feeder-free human embryonic and induced pluripotent stem cells upon passaging.

Authors:  Mohammad Pakzad; Mehdi Totonchi; Adeleh Taei; Ali Seifinejad; Seyedeh Nafiseh Hassani; Hossein Baharvand
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

9.  A combined epigenetic and non-genetic approach for reprogramming human somatic cells.

Authors:  Jinnuo Han; Perminder S Sachdev; Kuldip S Sidhu
Journal:  PLoS One       Date:  2010-08-19       Impact factor: 3.240

10.  Two factor reprogramming of human neural stem cells into pluripotency.

Authors:  Mark E Hester; Sungwon Song; Carlos J Miranda; Amy Eagle; Phillip H Schwartz; Brian K Kaspar
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.